David Nutt

Drug harms in the UK: a multicriteria decision analysis

David Nutt, Leslie A. King, Lawrence D. Phillips · The Lancet · 2010 · 1.6K citations

Drug Harms, Substance Abuse, Substance Use +8

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin Carhart‐Harris, Mark Bolstridge, James Rucker et al. · The Lancet Psychiatry · 2016 · 1.5K citations · Full text

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Robin Carhart‐Harris, David Erritzøe, James Stone et al. · Proceedings of the National Academy of Sciences · 2012 · 1.1K citations · Full text

Neuropsychology, Brain Function, Fmri Studies +24

Sleep disorders as core symptoms of depression

David Nutt, Sue Wilson, Louise M. Paterson · Dialogues in Clinical Neuroscience · 2008 · 787 citations · Full text

Sleep Disorders, Sleep Disturbance, Mental Health +16

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

David S. Baldwin, Ian Anderson, David Nutt et al. · Journal of Psychopharmacology · 2014 · 661 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +17